The Asia Pacific opioids drugs market is anticipated to register a significant growth rate at a CAGR of 3.02% during the projected period of 2019-2028. One of the major factors stimulating market growth in the region is the growing incidence of chronic pain in the region. In order to understand the growth potential of the Asia Pacific opioids drugs market further, the region is segregated into India, Japan, Vietnam, Thailand, Indonesia, China, Australia & New Zealand, South Korea, and the rest of Asia Pacific.

ASIA PACIFIC OPIOIDS DRUGS MARKET FORECAST 2019-2028

Asia Pacific Opioids Drug Market by Products (Buprenorphine, Fentanyl, Hydrocodone, Morphine, Oxycodone, Tramadol and Other Products), by Application (Pain Relief, Anesthesia, Cough Suppression, Diarrhea Suppression, Deaddiction) and by Geography.

Request free sample

The Asia Pacific opioids drugs market is anticipated to register a significant growth rate at a CAGR of 3.02% during the projected period of 2019-2028. One of the major factors stimulating market growth in the region is the growing incidence of chronic pain in the region.
Aisa Pacific Opioids Drug Marke

To know more about this report, request a free sample copy

In order to understand the growth potential of the Asia Pacific opioids drugs market further, the region is segregated into India, Japan, Vietnam, Thailand, Indonesia, China, Australia & New Zealand, South Korea, and the rest of Asia Pacific. In China, the high prevalence of chronic pain and cancer is driving the demand for pain-reducing drugs. The recent trade war between China, the United States, Europe, and the increasing addiction cases in importer countries are likely to impact the opioids market adversely. However, the rising incidence of chronic pain, and a surge in various government initiatives to curb the problem are augmenting the market growth. In counties like Japan, though there is a high prevalence of chronic pain in the adult population, there is a strong dislike towards narcotics due to restrictive laws and the stigma of addiction. The pattern of opioids usage is one daily dose, and with the outbreak of coronavirus, the Japanese prescribe far fewer opioids.

In India, people are in need of opioids for pain relief because of the prevalence of cancer and other life-threatening diseases. India exports several prescription-based products to the United States, and is the biggest supplier of the less potent opioid Tramadol to the Middle East and Africa. The growing government collaboration and stringent environmental regulations are boosting the market growth. South Korea is a hub for anesthetics. Various pain management drugs and devices are launched to address orthopedic and spinal problems. Due to the outburst of COVID-19, the prescription standards guide the doctors to prescribe opioids to patients with chronic non-cancer pain.

Sun Pharmaceuticals Industries Ltd, India’s top and world’s fourth-largest pharmaceutical company, markets about 2,000 products across the globe. The company and the AstraZeneca UK Ltd. announced an agreement in 2019. It was for introducing ready-to-use infusion oncology products in China.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • MARKET DEFINITION
      •    KEY DRIVERS
        • INCREASING ROAD ACCIDENTS AND SURGICAL PROCEDURES
        • ESCALATING PALLIATIVE CARE FOR PATIENTS SUFFERING INTENSELY
        • USAGE OF ABUSE DETERRENT FORMULATIONS TO RESTRICT THE OPIOID ABUSE
        • GROWING OCCURRENCE OF CHRONIC PAIN
      •    KEY RESTRAINTS
        • MISUSE OF OPIOIDS
        • STRINGENT REGULATORY FRAMEWORK
    1. KEY ANALYTICS
      • KEY INVESTMENT INSIGHTS
      •    PORTER’S FIVE FORCE ANALYSIS
        • BUYER POWER
        • SUPPLIER POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • REGULATORY FRAMEWORK
      • TECHNOLOGICAL ADVANCEMENT
    2. MARKET BY PRODUCT
      • BUPRENORPHINE
      • FENTANYL
      • HYDROCODONE
      • MORPHINE
      • OXYCODONE
      • TRAMADOL
      • OTHER PRODUCTS
    3. MARKET BY APPLICATION
      •    PAIN RELIEF
        • CANCER PAIN
        • POSTOPERATIVE PAIN MANAGEMENT
        • LOW BACK PAIN
        • ORTHOPEDIC
        • FIBROMYALGIA
        • NEUROPATHIC
      • ANESTHESIA
      • COUGH SUPPRESSION
      • DIARRHEA SUPPRESSION
      • DEADDICTION
    4. GEOGRAPHICAL ANALYSIS
      •    ASIA PACIFIC
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • VIETNAM
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA PACIFIC
    1. COMPANY PROFILES
      • ACURA PHARMACEUTICALS INC
      • ALLERGAN PLC
      • BIODELIVERY SCIENCES INTERNATIONAL INC
      • CIPHER PHARMACEUTICALS INC
      • COLLEGIUM PHARMACEUTICAL INC
      • DAIICHI SANKYO INC
      • EGALET CORP
      • HIKMA PHARMACEUTICALS PLC
      • INDIVIOR INC
      • JANSSEN PHARMACEUTICALS INC
      • JOHNSON & JOHNSON
      • LANNETT CO. INC
      • LUPIN LTD
      • MYLAN NV
      • PFIZER INC
      • PURDUE PHARMA LP
      • SANOFI-AVENTIS S.A
      • SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUN PHARMA)
      • TEVA PHARMACEUTICAL INDUSTRIES LTD

    TABLE LIST

    TABLE 1: MARKET SNAPSHOT – OPIOIDS DRUGS

    TABLE 2: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 3: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 4: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 5: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    TABLE 6: ASIA PACIFIC PAIN RELIEF MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION):

    TABLE 7: ASIA PACIFIC PAIN RELIEF MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION):

    TABLE8: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

    TABLE 9:  ASIA PACIFIC OPIOIDS DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

    FIGURE LIST

    FIGURE 1: KEY INVESTMENT INSIGHTS

    FIGURE 2: PORTER’S FIVE FORCE ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: ASIA PACIFIC OPIOIDS DRUGS MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2019

    FIGURE 6: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY BUPRENORPHINE, 2019-2028 (IN $ MILLION)

    FIGURE 7: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY FENTANYL, 2019-2028 (IN $ MILLION)

    FIGURE 8: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY HYDROCODONE, 2019-2028 (IN $ MILLION)

    FIGURE 9: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY MORPHINE, 2019-2028 (IN $ MILLION)

    FIGURE 10: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY OXYCODONE, 2019-2028 (IN $ MILLION)

    FIGURE 11: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY TRAMADOL, 2019-2028 (IN $ MILLION)

    FIGURE 12: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY OTHER PRODUCTS, 2019-2028 (IN $ MILLION)

    FIGURE 13: ASIA PACIFIC OPIOIDS DRUGS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2019

    FIGURE 14: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)

    FIGURE 15: ASIA PACIFIC PAIN RELIEF MARKET, BY CANCER PAIN, 2019-2028 (IN $ MILLION)

    FIGURE 16: ASIA PACIFIC PAIN RELIEF MARKET, BY POSTOPERATIVE PAIN MANAGEMENT, 2019-2028 (IN $ MILLION)

    FIGURE 17: ASIA PACIFIC PAIN RELIEF MARKET, BY LOW BACK PAIN, 2019-2028 (IN $ MILLION)

    FIGURE 18: ASIA PACIFIC PAIN RELIEF MARKET, BY ORTHOPEDIC, 2019-2028 (IN $ MILLION)

    FIGURE 19: ASIA PACIFIC PAIN RELIEF MARKET, BY FIBROMYALGIA, 2019-2028 (IN $ MILLION)

    FIGURE 20: ASIA PACIFIC PAIN RELIEF MARKET, BY NEUROPATHIC, 2019-2028 (IN $ MILLION)

    FIGURE 21: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY ANESTHESIA, 2019-2028 (IN $ MILLION)

    FIGURE 22: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY COUGH SUPPRESSION, 2019-2028 (IN $ MILLION)

    FIGURE 23: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY DIARRHEA SUPPRESSION, 2019-2028 (IN $ MILLION)

    FIGURE 24: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY DEADDICTION, 2019-2028 (IN $ MILLION)

    FIGURE 25: ASIA PACIFIC OPIOIDS DRUGS MARKET, COUNTRY OUTLOOK, 2018 & 2028 (IN %)

    FIGURE 26: CHINA OPIOIDS DRUGS MARKET, 2020-2028 (IN $ MILLION)

    FIGURE 27: JAPAN OPIOIDS DRUGS MARKET, 2020-2028 (IN $ MILLION)

    FIGURE 28: INDIA OPIOIDS DRUGS MARKET, 2020-2028 (IN $ MILLION)

    FIGURE 29: SOUTH KOREA OPIOIDS DRUGS MARKET, 2020-2028 (IN $ MILLION)

    FIGURE 30: INDONESIA OPIOID DRUGS MARKET, 2020-2028 (IN $ MILLION)

    FIGURE 31: THAILAND OPIOID DRUGS MARKET, 2020-2028 (IN $ MILLION)

    FIGURE 32: VIETNAM OPIOID DRUGS MARKET, 2020-2028 (IN $ MILLION)

    FIGURE 33: AUSTRALIA & NEW ZEALAND OPIOID DRUGS MARKET, 2020-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      •    ASIA PACIFIC
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • THAILAND
        • VIETNAM
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA PACIFIC
    1. MARKET BY PRODUCT
      • BUPRENORPHINE
      • FENTANYL
      • HYDROCODONE
      • MORPHINE
      • OXYCODONE
      • TRAMADOL
      • OTHER PRODUCTS
    2. MARKET BY APPLICATION
      •    PAIN RELIEF
        • CANCER PAIN
        • POSTOPERATIVE PAIN MANAGEMENT
        • LOW BACK PAIN
        • ORTHOPEDIC
        • FIBROMYALGIA
        • NEUROPATHIC
      • ANESTHESIA
      • COUGH SUPPRESSION
      • DIARRHEA SUPPRESSION
      • DEADDICTION

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type